CLNN
Clene (CLNN)
$05
About Clene (CLNN)
Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.
Details
Daily high
$5.40
Daily low
$5.01
Price at open
$5.01
52 Week High
$13.50
52 Week Low
$2.28
Market cap
59.5M
Dividend yield
0.00%
Volume
110,338
Avg. volume
109,397
P/E ratio
-1.49
Clene News
Details
Daily high
$5.40
Daily low
$5.01
Price at open
$5.01
52 Week High
$13.50
52 Week Low
$2.28
Market cap
59.5M
Dividend yield
0.00%
Volume
110,338
Avg. volume
109,397
P/E ratio
-1.49